Neurodegenerative Disorders Drug Market Variables, Trends and Scope Analysis by 2022

Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment, memory loss and declining cognitive ability. Neurodegenerative disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.

There are over 1,400 products in active development in the neurodegenerative disorders therapy area. The current market landscape consists of a number of biologics and small molecules, while the pipeline also consists of gene therapies and cell therapies, demonstrating broader pharmaceutical research and development.

Browse Detail Report With TOC @ http://www.hexareports.com/report/neurodegenerative-disorders-drug-development-pipeline-review-2017

Small molecule drugs dominate the pipeline, with approximately 64% of total pipeline molecules. In comparison, the number of biologics in the pipeline is lower, representing approximately 26% of the pipeline.

Overall the neurodegenerative disorders pipeline is large, with a substantial proportion of products being early-stage assets at the Preclinical development stage. The report provides comprehensive information on the pipeline development landscape for is Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis and Multiple sclerosis, from Discovery through to the Pre-registration stage.

Request A Sample copy of This Report @ http://www.hexareports.com/report/neurodegenerative-disorders-drug-development-pipeline-review-2017/request-sample

This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for neurodegenerative disorders?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

  1. Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  2. Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  3. Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  4. Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

Cardiovascular Disorders Drug Development Pipeline Review, 2017 –

http://www.hexareports.com/report/cardiovascular-disorders-drug-development-pipeline-review-2017

Colorectal Cancer – Heat Map and Analysis –

http://www.hexareports.com/report/colorectal-cancer-heat-map-and-analysis

Parkinson’s Disease – Heat Map and Analysis –

http://www.hexareports.com/report/parkinsons-disease-heat-map-and-analysis

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s